key: cord-0728615-oo8q6898
authors: Johnson, Richard T.; Major, Eugene O.
title: Chapter 40 Infectious Demyelinating Diseases
date: 2004-12-31
journal: Myelin Biology and Disorders
DOI: 10.1016/b978-012439510-7/50093-0
sha: 1926509a6cb035d657c351f7ffed2656469fd78b
doc_id: 728615
cord_uid: oo8q6898

Publisher Summary This chapter focuses on three human CNS demyelinating diseases—namely, acute disseminated encephalomyelitis (ADEM), also known as postinfectious encephalomyelitis, progressive multifocal leukoencephalopathy (PML), and multiple sclerosis (MS). These three diseases have very different clinical courses and distinctive pathological features, although all share the essential element of demyelination. ADEM and PML have antithetic modes of pathogenesis. ADEM is a predominantly extraneural infection resulting in a virus-induced host autoimmune response, whereas PML is a direct lytic infection of oligodendrocytes in an immunocompromised host. It is clear that a diverse array of viruses can infect the human central nervous system. The viral infections can result in a wide variety of clinical and pathological symptoms. While some viruses may cause widespread inflammation and neurodegeneration, other viruses may remain latent in the CNS and only produce pathological changes during reactivation. Viral induced demyelination can occur both from direct infection of the myelin-producing oligodendrocytes, as in PML, or by indirect mechanisms that have yet to be determined. The outcome of a viral CNS infection depends not only on viral characteristics, but also on the interaction between virus and host cell.

Viral infections can lead to acute or chronic demyelinating diseases of the central or peripheral nervous systems in animals and humans. These diseases can be acute or chronic with progressive or relapsing-remitting courses. The loss of myelin with relative sparing of axons may or may not be associated with inXammation or gliosis, and oligodendrocytes or Schwann cells may or may not be altered. The mechanisms of demyelination are varied.

Natural infections of rodents (mouse hepatitis and Theiler's viruses), canines (canine distemper virus), and ruminants (visna of sheep and caprine arthritis-encephalitis viruses) have been associated with central nervous system (CNS) demyelination; see Chapter 44. This chapter focuses on three human CNS demyelinating diseases: acute disseminated encephalomyelitis (ADEM), also known as post-infectious encephalomyelitis, progressive multifocal leukoencephalopathy (PML), and multiple sclerosis (MS).

These three diseases have very diVerent clinical courses and distinctive pathological features, although all share the essential element of demyelination. ADEM and PML have antithetic modes of pathogenesis; the former is a predominantly extraneural infection resulting in a virus-induced host autoimmune response, and the latter is a direct lytic infection of oligodendrocytes in an immunocompromised host. The role of infections in MS is unclear; epidemiological studies implicate an early life exposure in the genesis of the disease that could represent an infection. Exacerbations of disease more often follow virallike illnesses and patients with MS have abnormal immune responses to viruses, including the intrathecal generation of antibodies to measles and a variety of other agents.

Several mechanisms have been proposed to explain the demyelination seen with viral infections, and in MS when an infectious etiology has been postulated (Tab. 40.1). The most straightforward mechanism to explain CNS myelin loss is the selective destruction of the myelin maintaining cells, oligodendrocytes. This mechanism is responsible for the loss of myelin in PML, a disease characterized by infection and lysis of oligodendrocytes (discussed later).

In the immunocompetent host, immune responses are often proposed to explain myelin destruction. Most agents associated with CNS demyelination are enveloped viruses. Viral envelopes are formed by insertion of virus-coded proteins into the lipid bilayer of the cell membrane. The core or nucleocapsid of the virus then acquires the envelope by budding through the modiWed membrane. Hypothetically, immune responses against viral proteins within the membrane could caused myelin membrane damage in situ. Alternatively, virus replicating in oligodendrocytes could transport sequestered myelin antigens into the systemic circulation.

Infection of macrophages, microglia or astrocytes may release soluble cytokines, chemokines or viral proteins, which are toxic to other uninfected CNS cells. Visna virus infections of sheep have a long incubation period followed by either a progressive or remitting and relapsing course, accompanied by patchy demyelinated lesions simulating MS. However, infection is limited to cells of macrophage origin. In the brain, macrophages and microglia appear to release a cytokine or similar soluble substance that results in demyelination (Kennedy et al., 1985) . A related lentivirus, human immunodeWciency virus (HIV), has subsequently been shown to infect the same restricted cell population in the human brain. Viral proteins as well as cytokines released from infected macrophages and microglia have also been implicated in the pathogenesis of HIV encephalopathy (Power and Johnson, 2001) .

Demyelination can also result from immune responses against myelin in the absence of nervous system infection. Molecular mimicry, in which an immune response to an environmental agent cross-reacts with a host antigen, has been a popular postulated mechanism. A similar amino acid sequence contained in both viral protein and myelin proteins might allow systemic virus replication to induce an immune response against an epitope on the CNS myelin. Searching sequence databases for commonality of encephalitogenic sequences of myelin basic protein and viral proteins turned up a sequence within the P protein of hepatitis B virus. Inoculation of this synthesized viral sequence into rabbits resulted in an inXammatory response in the brain (Fujinami and Oldstone, 1985) . In natural infections, Camphylobactor infections followed by the axonal form of Guillian-Barre syndrome are probably due to similarities between bacterial and axonal proteins (Moran and Prendergast, 2001) , and cellular damage in HTLV-1-associated myelopathy (tropical spastic paraparesis) appears related, in part, to homology between nuclear ribonuclear neuronal protein and the tax protein of HTLV-1 (Levin et al., 2002) .

Finally, infection of lymphoid cells may disrupt normal cellular immune responses. Activated T cells normally traYc through the CNS, but only those recognizing an antigen remain (Irani and GriYn, 1996) . Thus, in systemic infections causing lymphocyte activation, CNS traYc of T cells is increased. If normally suppressed responses to self-antigens are disrupted by the infection, autoimmune disease can occur such as ADEM associated with measles virus infections (discussed later).

For over half a century, the focus on experimental autoimmune (allergic) encephalomyelitis (EAE) as the prototype autoimmune disease biased thought on virus-induced demyelination. In recent years, studies of humoral immune responses in the pathogenesis of Guillian-Barre syndrome and focus on toxic eVects of cytokines and viral proteins in studies of neurological complications of HIV infections have provided a more balanced perspective. Estimates diYcult to determine because of frequency of toxic encephalopathy or Reye's syndrome (diVerent pathology) and acute cerebellar ataxia (unknown pathology) and the rare documentation of perivenular demyelinating disease.

On microscopic examination mononuclear cells are prominent along the small veins. In intense acute cases, polymorphonuclear cells may also be present. Pallor and loss of myelin staining is seen along the vessels; its perivenular localization often produces Xame shaped lesions. In the spinal cord, this causes a characteristic radial pattern ( Fig. 40.1) , a pattern distinctive from the plaques of demyelination seen in PML or MS. Patients dying later in disease show even more sharply demarcated lesions and lipid-laden macrophages .

Immunocytochemical staining of myelin proteins also distinguishes ADEM from PML and MS. In ADEM, as in EAE, areas demonstrating loss of myelin basic protein and myelinassociated glycoprotein are concordant (Gendelman et al., 1984) . In PML, the area of myelin-associated glycoprotein loss is distinctly larger than the area of myelin basic protein loss in demyelinated lesions. Presumably this reXects a direct attack on the myelin membranes in ADEM and EAE; whereas in PML, where disease results from oligodendrocyte infection, the myelin-associated glycoprotein, concentrated in the periaxonal, most distal extensions of the myelin membrane, is lost Wrst. Thus, in PML lesions, areas of decreased myelin-associated glycoprotein staining are two to three times larger than areas of myelin basic protein loss. Demyelinated plaques in MS show a mixture of patterns, suggesting diVerent pathogenic mechanisms accounting for myelin loss (Gendelman et al., 1985) .

In acute hemorrhagic necrotizing leukoencephalitis, the brain is usually strikingly swollen with evidence of herniation. Gross hemorrhages are evident. Microscopically both veins and arterioles show Wbrinoid necrosis. This vascular necrosis is associated with transudates of Wbrin into the tissue, extravasation of red blood cells, and tissue FIGURE 40.1 ADEM following varicella. This 12-year-old girl developed paraparesis abruptly 2 weeks after the onset of uncomplicated chickenpox. Over the next 3 days the disease evolved with arm weakness, blindness, respiratory distress, seizures, and death. Section of spinal cord shows the characteristic pattern of perivenular demyelination. necrosis. The inXammatory inWltrate is predominantly polymorphonuclear. These Wndings are most intense in the white matter; and despite the large necrotic areas, there are regions where myelin loss with relative sparing of axons is evident.

The pathological changes in ADEM resemble those seen in the ''neuroparalytic accidents'' reported after post-exposure vaccination for rabies using killed virus prepared in animal brain and spinal cord. Indeed, the similarity between the demyelinating encephalomyelitis after vaccination with vaccinia virus to prevent smallpox and the complications of rabies vaccine led Rivers and Schwentker (1935) to studies in monkeys. Animals repeatedly inoculated with emulsions of normal brain developed neurological signs and had perivenular demyelination. This was the discovery of EAE. Subsequently Kabat and colleagues (1947) found that in some species, a single injection of brain could induce the disease if brain inoculum was emulsiWed in adjuvant. Others showed that speciWc sequences of myelin basic protein and proteolipid protein could cause disease, and that disease could be passively transferred with sensitized lymphocytes (Paterson, 1960 ) (see Chapter 43).

EAE mimics ADEM and post-rabies vaccine encephalitis (Tab. 40.3). Lymphocytes from patients with post-rabies vaccine encephalomyelitis (Hemachudha et al., 1988) , postmeasles encephalitis, post-varicella cerebellar ataxia, and encephalomyelitis following respiratory infections have been shown to proliferate when cultured in the presence of myelin basic protein. The gap in these parallels is that patients with ADEM have not been injected with myelin proteins.

Studies of the pathogenesis of ADEM have focused primarily on measles because the clinical diagnosis is easy, the incidence of ADEM is high compared to other infections, and the neurological complications of measles are homogeneous. Generalization of these studies to ADEM and other post-infectious complications of other viruses is cautioned, since the systemic pathogenesis and eVects on the immune system by the other agents are variable. (1908) demonstrated that children had a conversion of positive tuberculin reactions during measles, and for weeks thereafter. Subsequent studies showed inhibition of lymphocyte responses to mitogens for up to 4 weeks after uncomplicated measles virus infection. The magnitude of inhibition of lymphocyte proliferation was the same in children with uncomplicated measles, in those with pneumonitis related to immunodeWciency, and in those with ADEM thought to be due to an autoimmune response (Hirsch et al., 1984) . In contrast, spontaneous proliferation of CD4, CD8, and B lymphocytes was found, as well as signs of immune activation, which included lymphoproliferation of lymphocytes in the presence of myelin basic protein in 15% of cases of uncomplicated measles and in 47% of those with ADEM (Johnson et al., 1984) . The mechanisms underlying the profound suppression of cell-mediated immunity accompanying measles is still not fully understood. In vitro infection of human monocytes speciWcally down-regulates IL-12 production, a cytokine critical in cell-mediated immunity (Karp et al., 1996) , however disruption at other sites in the complex cytokine network is likely.

In a subsequent study of ADEM after varied infections, T-cell lines were established from patients. The frequency of cell lines reactive to myelin basic protein was ten times higher in patients with ADEM than patients with encephalitis or controls. IL-4 was the prominent cytokine secreted by T-cell lines from patients with ADEM during the recovery phase (Pohl-Koppe et al., 1998) . This Wnding supports a more general relevance of T-cell responses to myelin proteins in the pathogenesis of ADEM.

ADEM is best deWned by its unique pathology, because many of the causative agents are associated with multiple post-infectious syndromes and many of the clinical syndromes and imaging studies overlap with other disease processes. The two most clearly deWned cases of ADEM are those following vaccinia and measles virus infections. Each follows a clinically distinct exanthem and presents a similar clinical course and consistent pathology. In contrast, neurological syndromes associated with rubella, varicella, mumps, and inXuenza may include direct encephalitis, Reye's syndrome, and acute cerebellar ataxiaall of which may have diVerent mechanisms of pathogenesis not characterized by demyelination (Tab. 40.2).

The common clinical features are a lag of 3 days to 3 weeks after the exanthem or respiratory disease, an abrupt onset of headache, fever, and impaired consciousness, and the Wnding of focal neurological signs. The disease reaches a nadir within days, and recovery is variable, depending, in large part, on the causative agent. The spinal Xuid usually shows a modest pleocytosis and mild protein elevation, but can also appear normal. The myelin basic protein content may be elevated, particularly early in disease. In some cases, magnetic resonance imaging has proved an eVective method of diVerentiation from acute encephalitis or Reye's syndrome. Multifocal white matter lesions of similar age are found, which may or may not enhance. When enhancement is seen in all lesions simultaneously ( Fig. 40. 2), the image is characteristic of ADEM.

Acute ADEM not associated with viral exanthems can be diYcult to diVerentiate from acute viral encephalitis or, in some cases, the initial attack of MS. A viral prodrome, high lesion load on magnetic resonance imaging involving deep gray matter, and the absence of oligoclonal bands in the spinal Xuid favor a diagnosis of ADEM (Hynson et al., 2001) . Followup studies of patients diagnosed with ADEM have shown a subsequent diagnosis of MS in some patients, raising the question of whether ADEM might be a part of an ''MS spectrum'' (Hartung and Grossman, 2001) . MS is not, however, an outcome of classical ADEM following measles or vaccinia infections, and ADEM has a very distinctive neuropathology.

Measles probably remains the most common cause of ADEM worldwide. Although indigenous measles has been eliminated from the Western Hemisphere and Western Europe, it still causes over 1 million childhood deaths each year, largely in developing countries. Measles continues to rank as the third most common infectious cause of childhood death worldwide, following diarrheal illnesses and malaria. The most frequent fatal complications of measles, pneumonitis, gastroenteritis, and secondary bacterial infections, result from a depression of cell-mediated immune responses extending for 1 to 4 weeks after the rash. Prior to the emergence of HIV, measles virus was the most important and lethal causes of a virus-induced immunodeWciency syndrome. However, the major neurological complication of measles infection, ADEM, was assumed to be an allergic or autoimmune disease. Although this initially appeared to be a paradox, studies of measles and HIV have shown that immune activation can suppress immune responses as well as release autoimmune responses.

The incidence of post-measles encephalitis is reasonably constant, at about 1 per 1000 cases, and is age dependent, since children under 2 years of age seldom develop encephalitis. It does not appear to be nutritionally dependent, as are some opportunistic infections. Thus, populations such as those of West Africa tend to suVer high rates of measles mortality from opportunistic infections and infant deaths. On the other hand, more aVluent countries without adequate immunization programs have greater mortality and morbidity from post-measles encephalitis, because older children become infected. Although polyneuritis, toxic encephalopathy and acute hemiplegia of possible vascular etiology have been reported with measles, over 95% of the neurological illnesses are represented by ADEM. The incubation period of measles is 10 to 14 days. The prodrome and period of infectivity is marked by coryza, conjunctivitis, cough, and the pathognomonic Koplik spots on the buccal mucosa. Coincident with the antibody response and the end of infectivity, a maculopapular rash develops on the face and trunk, later spreading to the extremities. Virus can be recovered from the rash, and for up to 5 days after the appearance of the rash, viral antigen or RNA can be found in epithelioid cells of the lung, gut, bladder, and lymphoid organs (Moench et al., 1988) . On rare occasions, viral antigen and RNA can also be detected in cerebrovascular endothelial cells (Esolen et al., 1995) . Although there is no evidence of infection of neural cells, approximately 50% of children have an abnormal electroencephalogram during the rash (Gibbs et al., 1959) , and approximately 30% have a pleocytosis (Ojala, 1947) .

Post-measles encephalitis typically develops 4 to 5 days after the onset of the rash, but may precede the rash or be delayed until 3 weeks after. Typically the child is afebrile, the rash is fading and the child is returning to normal activities, when fever returns with headache. Obtundation is frequent and may progress to coma. Generalized or focal seizures occur in about half of the children. Multifocal neurological signs may include cranial nerve abnormalities, pyramidal tract signs, abnormal movements, and ataxia. Sensory deWcits are infrequent. The spinal Xuid may show a modest mononuclear cell pleocytosis but is acellular in about one-third of the patients. Protein elevations are variable, but many have high levels of myelin basic protein in spinal Xuid, particularly early in the course of the encephalitis. Elevated IgG synthesis and oligoclonal bands are usually absent (Johnson et al., 1984) . Mortality and morbidity are high. Between 10 and 40% mortality are reported, and neurological sequellae are found in the majority of survivors. Prognosis has been linked to length of stupor or coma (Tyler, 1957) , but remarkable recoveries can be seen after prolonged coma (Johnson et al., 1984) .

The measles vaccine is an attenuated live virus, which has led to the question of whether or not the vaccine may, on rare occasions, cause ADEM. The vaccine virus can produce fever, but in early tests of the vaccine, no abnormalities were found on electroencephalograms that are common with wild-type virus infections. Post-liscencing studies reported one case of encephalitis per million children following vaccination, a number lower than the observed background of two per million cases of encephalitis or encephalopathy per month, suggesting a coincidental relationship between vaccine and disease. Further analysis, however, showed some clustering of cases during the 6 to 15 days after immunization, suggesting a possible relationship (Landrigan and Witte, 1973) . Since no histopathological studies have been reported in post-vaccine illnesses, whether or not a few of these cases represent rare cases of ADEM remains unknown.

Until recently, the neurological complications of smallpox and vaccinia were of only historical interest; the last case of natural smallpox was observed in 1977, and within a few years vaccinia inoculation had been abandoned worldwide. Recent threats of bioterrorism have led to consideration of renewed vaccinia virus inoculation, and the risks of ADEM must be reconsidered.

In retrospect, ADEM accompanied smallpox but was hidden under the devastating systemic disease (Marsden and Hurst, 1932) . In the 1920s, ADEM became appreciated as a complication of immunization with vaccinia virus. The incidence of complications after vaccination is extraordinarily variable; an incidence of 1 in 63 is cited for one Dutch vaccine program (but a variety of types of illness were included) (DeVries, 1960) . During World War II, an incidence of post-vaccinal encephalomyelitis in England was estimated 1 per 175,000 (Miller, 1953) , a subsequent retrospective analysis in the United States estimated 1 per 200,000; during the sidewalk vaccination of 5 million people in New York in 1947 a similar incidence of about 1 per 100,000 was estimated, and during the more recent mass vaccination during the smallpox outbreak in the United Kingdom in 1962, passive reporting estimated neurological complications in 1 per 20,000 (Spillane and Wells, 1964) . The variation in incidence may be due to diVerent ethnic populations, diVerent patches of virus, and certainly variable and often poor data collection. ADEM is clearly more common with primary immunization, and some data suggest that incidence increases with age.

At the time of maximal cutaneous reaction or shortly thereafter, patients with ADEM develop fever, nuchal rigidity and obtundation, Movement disorders including tremor, ataxia, trismus, and myoclonus are speciWcally mentioned in several reports (Miller and Stanton, 1954; Spillane and Wells, 1964) . Fatality rates are as varied as incidence rates, but are generally lower than those for post-measles encephalomyelitis, and sequellae are less frequent.

The pathogenesis is assumed to resemble that of measles, but vaccinia virus usually replicates only in the dermis. In some patients a viremia is found, and this is more prolonged in patients with ADEM. Virus has been recovered from brains and spinal Xuids of patients with ADEM (Brooks, 1979) . Which hematogenous cells are infected and the eVect on immune responses has not been studied.

In considering the resumption of vaccination some have recommended (1) vaccination of those likely to encounter victims (Wrst-responders, family health care providers, and clinic and emergency room personnel), (2) vaccination of all who request vaccine, or (3) mandatory universal vaccination. In any of these scenarios, most of those receiving vaccine would be over age 2 and a majority would be receiving primary vaccinations, two factors that presumably increase the risk of ADEM. If the incidence of ADEM were 1 per 20,000 vaccinees (some would consider that Wgure high; others low) in the United States, we might anticipate 10,000 cases of ADEM with 1000 deaths if universal immunization were the option chosen.

Of the neurological complications accompanying chickenpox, fully 50% are acute cerebellar ataxia, which complicates 1 in 4000 chickenpox cases. Typical ADEM is quite rare but does occur ( Fig. 40 .1). The most dreaded complication is Reye's syndrome, in which fatty degeneration of the liver is accompanied by life threatening brain edema, but in this disease both inXammation and demyelination are absent.

Post-varicella cerebellar ataxia has a good prognosis and the absence of fatalities leave the histopathology undeWned. In several cases of acute ataxia with chickenpox, lymphoproliferative responses in the presence of myelin basic protein have been reported, suggesting a pathogenesis similar to post-measles encephalomyelitis (Johnson et al., 1984; Lisak et al., 1977) . Antibodies reacting with sections of cerebrum and cerebellum were reported in 3 of 8 children with post-varicella cerebellar ataxia, suggesting that humoral immune responses may also be involved (Adams et al., 2000) .

The typical ADEM resembles post-measles ADEM; disease onset is abrupt at 4 to 15 days after the onset of rash. Fever, headache, obtundation, seizures, and focal neurological signs are common (Gollomp and Fahn, 1987) . Neuropathological studies are similar.

Rubella is the fourth exanthem classically associated with ADEM. It is estimated that an incidence of 1 per 20,000 cases develop ADEM. The onset is typical; during the week after the rash, fever, headache, and obtundation develop often with seizures. Focal neurological signs are usually not found, but a pleocytosis is. Fatalities do occur, but most have failed to show the typical hallmarks of ADEM; a minority has shown characteristic perivenular inXammation and demyelination suggesting varied types of post-rubella encephalopathies. In a single child, a lymphoproliferative response to myelin basic protein was documented .

HIV has been associated with a remarkable spectrum of neurological diseases. Acute meningitis and acute demyelinating polyneuritis (Guillian-Barre syndrome) have often been seen about the time of initial seroconversion. These are assumed to be autoimmune disorders associated with the initial activation of CD4 cells. A small number of newly infected individuals have developed a fatal encephalomyelitis, and pathological studies have shown ADEM (Narciso et al., 2001; Silver et al., 1997) .

Years later with onset of AIDS diVerent central and peripheral nervous system diseases are prominent associated with intense immunodeWciency. HIV dementia, which develops in 20 to 40% of AIDS patients, can be characterized by ''diVuse myelin pallor,'' visualized on magnetic resonance imaging as a hypodense lesion of white matter, primarily in the cerebral hemispheres, and in pathological sections by a pallor of myelin staining. Initially thought to represent demyelination, immunocytochemical staining for myelin proteins has failed to show myelin loss. The abnormal signal on imaging and pallor of staining seem to reXect a breakdown of the blood-brain barrier (Power et al., 1993) . In addition to the prominent diVuse pallor of myelin, small Xame-shaped areas of demyelination without inXammation are occasionally seen along vessels; these may represent the residua of minor or subclinical demyelinating encephalitis that occurred at the time of seroconversion.

Several viruses have been associated with ADEM that are also associated with apparent acute encephalitis or meningitis. In neurological complications of mumps virus, EB virus, and inXuenza A and B virus infections, virus has been recovered from brain or spinal Xuid and pathological Wndings have been varied; some suggest direct eVects of virus replication in neural cells and some histopathologically are ADEM (Hart and Earle, 1975) .

Mumps was the single most common viral cause of viral meningitis, but over 90% of these illnesses are now prevented in countries with adequate MMR vaccine administration. Indeed, mumps may be the most neuroinvasive virus, since examination of spinal Xuid in patients with uncomplicated parotitis showed that fully 50% had a pleocytosis. Fortunately, mumps is not highly neurovirulent, and the common neurological complication is benign meningitis. In patients with mumps meningitis, virus can readily be isolated from spinal Xuid, and viral nucleocapsids can be visualized by electron microscopy within ependymal cells found in spinal Xuid . This suggests a similar pathogenesis of CNS invasion in humans as seen in hamsters, where mumps virus selectively infects ependymal cells (Johnson, 1968) . Serious CNS complications of mumps virus infections are rare. Even prior to immunization, when mumps virus infection was universal, only four to Wve deaths from mumps encephalitis were reported to the Centers for Disease Control each year. Of those cases, about half showed the histological Wndings of perivenular demyelination (Schwarz et al., 1968) .

The neurological complications of EB virus infections pose an even more confusing spectrum of disease. Typically these disorders arise 1 to 2 weeks after the onset of clinical infectious mononucleosis. About 1% of patients have neurological complications, but these vary from Guillian-Barre syndrome and acute cerebellar ataxia (usually associated with autoimmune responses) to meningitis, encephalitis, and myelitis typical of direct infections (Gautier-Smith, 1965) . The Wnding of viral DNA by PCR is not meaningful, since EB virus is latent in B lymphocytes and a single B cell traversing through cerebral circulation or drifting into spinal Xuid could give a positive signal. As with mumps virus infections, intrathecal antibody synthesis and oligoclonal bands of IgG in the spinal Xuid may be found; this is in contrast to post-measles encephalomyelitis but does not exclude an immunopathological mechanism. Again, the diagnosis of ADEM is pathology-based. In the rare fatal cases of encephalitis, a necrotizing polioencephalitis is found; but in others perivenular demyelination has been reported (Paskavitz et al., 1995) .

Both inXuenza A and B have been, on rare occasions, related to Reye's syndrome, acute transverse myelitis, and Guillian-Barre syndrome. The association with pathologically ver-iWed ADEM is very rare (Hoult and Flewett, 1960) . Mycoplasma pneumonia is also associated with a variety of neurological complications including the occasional case of ADEM (Riedel et al., 2001) . A diagnosis of ADEM is often entertained clinically, but autopsy studies of fatal cases have generally shown brain edema or perivascular inXammation without convincing demyelination. Recent anecdotal reports of probable ADEM associated with hepatitis C virus (Sacconi et al., 2001) , attenuated polio vaccine virus (Ozawa et al., 2000) , and acute herpetic gingivostomatitis (Ito et al., 2000) may be coincidental.

This acute hemorrhagic disease has been regarded as a more intense form of ADEM and as a distinct entity. The clinical setting is similar. Usually 1 to 20 days following a virus-like illness, the disease develops with fever, obtundation, seizures, and focal neurological signs. Although reported in individual cases after measles and chickenpox, most follow a non-speciWc upper respiratory infection. In Asia, a number of cases have been associated with inXuenza virus infections (Voudris et al., 2001) ; recently several cases were reported with Mycoplasma pneumoniae infections (Pfausler et al., 2002) . In contrast to ADEM, the illness is fulminant with signs suggesting an expanding mass lesion, and the majority of patients die within 5 days. The spinal Xuid shows polymorphonuclear cells and red cells; in addition, a peripheral leukocytosis and proteinuria are usually found.

The arguments linking acute hemorrhagic necrotizing leukoencephalitis to ADEM are (1) the similar clinical setting despite a distinct spectrum of precipitating illnesses, (2) an apparent continuum of pathology with cases clearly showing features of both diseases, and (3) the animal model of hyperacute EAE that resembles hemorrhagic necrotizing leukoencephalitis (Levine and Wenk, 1965) . In a single case, a proliferative response of the patient's lymphocytes was demonstrated when cultured with myelin basic protein (Behan et al., 1968) .

Few arenas of medicine have celebrated the extraordinary success in disease prevention at as an astonishing cost-beneWt ratio as in the prevention of infections with vaccines. The measles vaccine alone prevents between 2 million and 3 million deaths each year, reduces the burden of permanently neurologically impaired by even greater numbers, has reduced childhood deafness by 10%, and has virtually eliminated subacute sclerosing panencephalitis from countries with sustained vaccine programs. The cessation of vaccination to prevent smallpox and the introduction of vaccine programs to prevent mumps, rubella, and chickenpox have decreased the incidence of ADEM dramatically.

Treatment is less eVective. Although the literature abounds with anecdotal claims of the beneWts of corticosteroids, no randomized placebo-controlled study supports their value. Several studies of sequential patients with measles encephalitis who did or did not receive steroids or ACTH showed no diVerence in mortality or morbidity (Ziegra, 1961) . These studies may be applicable only to measles, and empiric treatment with steroids remains common in ADEM, particularly when there is any evidence of increased intracranial pressure. One retrospective study of post-infectious encephalomyelitis showed higher mortality and morbidity rates among those who had received corticosteroids. On the assumption that the more seriously ill would tend to be treated, the data were reanalyzed to include only patients admitted in coma. Even in this reevaluation the mortality was higher in treated patients (Boe et al., 1965) .

Supportive treatment is important since children can have remarkable recoveries after prolonged coma. Therefore lowering of fever, management of seizures, careful management of Xuids, reducing increased intracranial pressure, and prevention of urinary and respiratory tract and skin infections are paramount. Mechanical ventilation is often necessary.

In the 1950s, a rapidly progressing neurologic syndrome was observed in a patient suVering from chronic lymphatic leukemia (CLL). Although the cause was ruled to be a result of leukemic cells that had inWltrated the brain, post-mortem examination revealed bizarre, enlarged nuclei and demyelination, which was not consistent with the diagnosis. A few years later, another patient with CLL developed similar neurologic symptoms. Again, autopsy revealed demyelinated plaques populated by cells with enlarged, dense nuclei, which were hypothesized to be oligodendrocytes with an unusual, undescribed pathology. The results were published in 1958 as the Wrst clinical and neuropathological description of a new disease, progressive multifocal leukoencephalopathy (PML), also known as Richardson's disease after E. P. Richarson, who was responsible for the initial description (Astrom et al., 1958) . There were early suspicions that PML was caused by a virus; however, the etiologic agent was not identiWed until 1971 as the human polyomavirus, JC Virus. Like other polyomaviruses, JCV was named after the initials of the patient from whom virus was Wrst isolated (Padgett et al., 1971) Initially the disease was mainly associated with patients suVering from lymphoproliferative and myeloproliferative diseases such as CLL, Hodgkin's disease, and sarcoidosis (Richardson, 1974) . Following the description of PML, retrospective review of the literature uncovered several similar accounts in patients with dementia suVering from a variety of underlying immunosuppressive disorders. The accounts dated back as far as 1930 with pathologic features consistent with PML (Hallervorden, 1930) . PML is almost exclusively associated with an underlying cellular immunodeWciency. Prior to the AIDS epidemic, the association was most frequently observed in patients with Hodgkin's disease and CLL. In the decades following, the exponential rise in the incidence of AIDS resulted in a much larger and rapidly growing population of immunosuppressed individuals. Presently, PML has become an increasingly common complication in AIDS patients, and has been the AIDS deWning illness in approximately 1% of the cases. It is expected that approximately 4 to 5% of all AIDS patients will eventually develop this disease (Berger and Major, 1999) .

JCV is a small, noneneveloped virus, approximately 45 nm in diameter. The viral capsid is icosahedral in symmetry, and made up of the 3 viral capsid proteins encoded by the late region of the JCV genome. After translation and transcription in the cytoplasm, nuclear localization signals located on the amino terminal region transport the proteins to the nucleus, where the virion particles are assembled (Moreland and Garcea, 1991) . Capsid assembly is governed by the major structural protein, Vp1, which accounts for more than 70% of the entire viral protein content. Vp1 also contains the antigenic epitopes to which a speciWc antibody response is mounted, and it is responsible for the ability of JCV to agglutinate human type O erythrocytes (Shah et al., 1977; Wang et al., 1999) .

Located inside the viral capsid are the JCV minchromosomes, each of which is a single molecule of viral DNA complexed with cellular and nuclear histones. The complete genome is a closed, circular supercoiled structure, approximately 5.13 kb in length (Frisque et al., 1984) . Transcription occurs in both directions starting from the highly conserved origin of replication, marked by a single EcoR1 restriction site. Extensive sequencing data has revealed that the genome can be functionally divided into three regions: the early region, encoding two nonstructural proteins; the late region, encoding three capsid proteins; and the regulatory region. The early region, located on the proximal side of the origin, is transcribed and expressed early after viral entry. Counterclockwise transcription of this region starting from the EcoR1 site, followed by diVerential splicing, produces two major mRNA species encoding the Large T and small t antigens. It is known that Large T is a nonstructural, DNA binding protein with multiple functions (Fanning, 1992) , one of which is the initiation of JC viral DNA replication by the unwinding and separation of the two strands of DNA so that the polymerases can function. Furthermore, it autoregulates to prevent transcription of the early genes during the later stages of infection, when the structural genes are being produced. Large T also plays a part in the malignant transformation of cells by binding to cell cycle regulatory proteins as well as tumor suppressors such as p53 and pRB, resulting in cellular malignant transformation.

The late region, located on the distal side of the origin, is encoded in the strand of DNA complementary to the strand that encodes the early genes. Clockwise transcription from the origin of replication yields the capsid proteins VP1, VP2, and VP3, as well as the Agnoprotein. VP1, VP2, and VP3, as discussed earlier, are the structural proteins that make up the viral capsid. Agnoprotein in related viruses has been implicated in DNA binding and localization of VP1 to the nucleus (Cole, 1996, Carswell and Alwine, 1986) . A recent report describing the presence of JCV agnoprotein in the cytoplasm of infected cells, suggests that protein shuttles freely between the cytoplasm and the nucleus and is important for JCV proliferation (Okada et al., 2001) . Early gene expression must take place before viral DNA replication can proceed, since the early products, Large T and small t, are necessary for the expression of the late gene products. Thus, eYcient expression of those late structural proteins occurs only after viral transcription and translation have taken place. The noncoding sequences located between the early and late genes contain the origin of replication, the JCV promoter, and enhancer sequences. Collectively, this area is also known as the viral regulatory region (RR), thought to control host range for lytic infection.

Studies of JCV infection in various cell types have demonstrated the extremely narrow host range of this virus. It has been shown that in cell culture systems, human glial cells are the most susceptible to infection as well as the most conducive to virion production (Wroblewska et al., 1980) . It was originally hypothesized that the Large T viral protein deWned the neurotropism of JCV, since the virus was shown to be able to replicate in nonglial cell types only in the presence of JCV or SV40 Large T protein, both of which share signiWcant homology (Feigenbaum et al., 1987) . Subsequent studies interchanged the JCV promoter with other viral promoters and used the constructs to infect various cell types. The results have suggested that the cell type speciWcity of JCV may also be a function of the viral promoter (Feigenbaum et al., 1992) . The restricted growth in cell types from extra neural tissue such as kidney and tonsil has led to questions regarding the nature of JCV susceptibility. Is JCV host cell restriction at the level of binding and entry or is it at the molecular level? The recent identiWcation of the speciWc cell surface receptor for JCV has provided some answers to these questions (Liu et al., 1998) . The receptor, an a 2-6 linked sialic acid, is a commonly expressed ganglioside found on the surface of various cells. Indeed, binding studies of JCV have shown that the virus can bind to and enter numerous cell types via this receptor, both susceptible and nonsusceptible.

Thus, unlike other viruses, viral susceptibility to JCV is not a function of speciWc receptor binding and entry. The focus has now shifted to intracellular factors that may contribute to the speciWcity of this virus. The regulatory region of JCV has several binding sites for the NF1 family of transcription factors. A comparison of relative NF1 expression between highly susceptible cells from the human fetal brain (HFB) and a nonsusceptible epithelial cell line (HeLa), demonstrated that one class in particular, NF1-D, was elevated in the HFB cells (Sumner et al., 1996) . Further studies have shown that overexpression of NF1-D in a normally nonpermissive cell line can render the cells susceptible to JCV infection, as determined by early and late gene production (Monaco et al., 2001) . The regulatory region of this virus has been of much interest, because it is becoming increasingly clear that despite eVective virus binding or the presence of viral DNA in the cells, productive infection only occurs in the cell types that express the appropriate transcriptional factors. The very narrow host range and the cell type speciWcity of JCV are unique properties of this virus.

It would be expected that the incidence of PML would be higher in the geographic areas coinciding with a large HIV infected population. However, since the technology required to make a deWnitive diagnosis of PML may not readily be available in such areas, the actual incidence of this disease may be masked to some extent. As such, the entire worldwide incidence of PML has not yet been determined. However, serological studies of human polyomaviruses in geographically isolated regions have yielded much information on the natural distribution of JCV in human populations. The Wrst study published in 1973 described a random sampling of 406 individuals from the state of Wisconsin, screened for the presence of JCV antibodies. The results showed that approximately 70% of assayed individuals had signiWcant antibody titers to JCV in their blood. However, the percentage dropped dramatically in very young children, suggesting that initial infection and seroconversion most likely occurs during early childhood (Padgett and Walker, 1973) . Much larger studies were conducted shortly thereafter to study the worldwide distribution of human polyomaviruses. Again, JCV infection was prevalent worldwide, as demonstrated by the presence of antibodies in infected individuals. The majority of adolescents and a much higher percentage of adults (80%) showed elevated levels of JCV-speciWc antibodies (Brown et al., 1975,Walker and Padgett, 1983) .

A more recent epidemiological study of the incidence of PML in the United States was conducted from 1979 to 1994. The survey reported the incidence of PML among HIV infected individuals as 1.6%. However, since the data only included PML cases that were diagnosed ante mortem, and not new cases discovered at autopsy, the authors felt that the numbers were an under-representation of the actual prevalence of the disease. It was also reported that 89% of the PML cases were attributed to HIV infection during this time period (Holman et al., 1991) . A recently concluded seroepidemiological study examining the circulation of human polyomaviruses in the population determined that 80% of the population exhibited antibodies to JCV (Maher, D. et al., in press).

The exact route of JCV transmission, initial infection and pathogenesis continues to be investigated. Seroepidemiologial studies have proven that the majority of the healthy, human population has antibodies against the virus, although the percentage drops in very young children. Thus, it is postulated that initial infection and seroconversion occurs within the Wrst 6 years of life with no associated clinical symptoms. The initial route of infection remains elusive, although one study has reported JCV replication in human tonsillar tissue, implicating a site of latency and also a primary infection route via inhalation (Monaco et al., 1998) . TraYcking B lymphocytes (Tornatore et al., 1992) may then carry the virus from the tonsillar and stromal tissue to other latent sites, including the bone marrow, tonsils, colon epithelial cells, and kidney (Jensen and Major, 1999; Laghi et al., 1999) (Fig. 40.3) . It is well documented that the virus is excreted in the urine of healthy individuals as well as patients with PML (Agostini et al., 1996) . Transmission via this route is unlikely, however, because the predominant genotype found in urine isolates has not be shown to be able to cause a robust infection in any type of human cell (Ault, 1997) . Systemic circulation of the virus to these diVerent compartments is thought to be via a hematogenous route, most likely involving infected B lymphocytes. Lymphocytes may shuttle the virus across the blood brain barrier during a period of severe immune deWciency, which sets the stage for the onset of PML when JCV infection is passed from the lymphocytes to the highly susceptible glial cell population.

The initial descriptions of PML were focused on the histopathological features associated with the disease, such as the enlarged oligodendroglial nuclei and bizarre, giant astrocytes. The swollen nuclei of infected oligodendrocytes usually display a change in chromatin pattern. They often appear more homogenous or will have the chromatin concentrated at the periphery, near the nuclear membrane. The nuclei have also been described as having ''ground glass'' appearance, which is due to the presence of numerous inclusion bodies. Electron microscopy has revealed that these inclusion bodies are actually a dense, crystalline, or Wlamentous array of JC virion particles (Aksamit, 1995) .

Upon gross examination, demyelinated plaques and lesions can be visible to the naked eye. The foci of demyelination are initially few and randomly distributed. They can range in size from millimeters to centimeters in diameter, occasionally coalescing to form even larger lesions. The lesions have been identiWed throughout the white matter of the brain, including the cerebral hemispheres, cerebellum, medulla, and even spinal cord. However, lesions are most commonly located in the subcortical white matter, near the gray-white matter junction, which is an area of increased cerebral blood Xow. This lends support to the hypothesis of viral entry into the CNS via hematogenous dissemination. However, lesions do not follow the cerebral vasculature of the brain. Microscopic examination of the plaques shows lytic destruction of oligodendrocytes, myelin degradation, but sparing of the associated axons. Active viral replication and capsid formation in infected oligodendrocytes is followed by cytolysis and viral release to surrounding cells. Susceptible cell types will follow the same pattern, resulting in a lesion where infected oligodendrocytes are concentrated at the periphery, encroaching outwards as the lesion grows. Thus, JCV is disseminated by cell-to-cell contact. Oligodendrocytes can be found throughout the lesion, often with enlarged, basophilic nuclei. Astrocytes found in this area may be hypertrophied and severely enlarged, while neurons are typically spared. In some cases, lipid-laden macrophages have been identiWed in the center of the lesions as well, evidence of active myelin degradation.

The mechanism behind JCV induced demyelination is primarily through the lytic infection of oligodendrocytes. However, there is some evidence that JCV large T protein Pathogenesis of progressive multifocal leukoencephalopathy. Primary infection is followed by an extended period of latency in several anatomical compartments. Current data implicate the kidneys and bone marrow as potential sites for JCV latency ( * ). Active JCV replication has been demonstrated in tonsillar tissue as well as in kidney ( { ). Following viral activation, infected B lymphocytes may traYc the virus across the blood brain barrier and into the parenchyma of the brain, where the infection is then passed to the highly susceptible glial cell population, ultimately resulting in the pathological and clinical symptoms associated with PML. may interfere with the production of myelin. InXammatory inWltrates are rare in PML, although there is a pronounced active astrocytosis in the lesions.

Besides the onset of clinical symptoms, one of the Wrst indicators of PML is a lesion visualized by CT or MRI. Lesions are often diYcult to attribute to a speciWc disease because, radiologically, they can appear very similar. As a general rule, PML lesions are multifocal and noncontrast enhancing. The location and extent of lesioning can vary, however. As such, radiographic imaging cannot be used alone to diagnose PML.

Neuroimaging has remained one of the most important tools in studying the PML patient (Thurnher et al., 1997) . The noninvasive visualization of lesions is helpful for a preliminary diagnosis, especially in cases where suspected lesions are in areas where the risk of biopsy is too high. By computerized tomography (CT) scan, the demyelinated lesions appear as asymmetrically distributed subcortical areas of decreased signaling intensity. Contrast enhancement is very rarely seen, indicating an intact blood brain barrier. CT scans are limited in detecting the extent of lesions occurring deeper in the brain, such as in the cerebellum or brainstem.

Magnetic resonance imaging (MRI) is extremely sensitive in determining not only the number of lesions, but the extent as well. In fact, MRI has been shown to be more sensitive than CT in both aspects, often revealing lesions where the CT scan previously appeared normal. As such, MRI is the preferred diagnostic technique for the evaluation of potential PML cases. In contrast to the hypodense lesions seen in CT scans, demyelinated lesions appear as patchy areas of increased signal intensity by T2 weighted MRI. T1 weighted images exhibit a decrease in signal intensity, as opposed to the hyperintense T2 weighted images. T1 related decrease in signal intensity is consistent with demyelination.

Metabolic assays generally have not been of much use in studying PML because lesions tend to occur either in the myelinated white matter or at the gray white matter junction.

Viral reactivation and lytic JCV infection of oligodendrocytes can cause demyelination in any white matter tract located throughout the brain. The clinical symptoms seen in PML patients are consistent with the extent and location of subcortical white matter destruction, with no inXammatory changes in the CSF. Furthermore, the spectrum of symptoms in HIV-associated PML patients is nearly identical to that of PML associated with other underlying immune deWciencies. The most common presenting symptoms are known collectively as the ''triad,'' which include a progressive deterioration of visual, motor, and cognitive functions. In HIV associated PML cases, the onset of neurological signs and symptoms may actually precede a diagnosis of AIDS in HIV infected patients and has been added to the list of AIDS deWning illnesses.

The most common presenting ailments are motor abnormalities. By the time of diagnosis, the majority of patients will exhibit signs of moderate to severe weakness, which typically aVects limbs on one side of the body (hemiparesis). Gait abnormalities (Berger and Major, 1999) or diYculty performing routine motor tasks are often accompanied by complaints of lethargy or impaired movement of the arms and legs. Visual deWcits also account for a signiWcant percentage of presenting symptoms. The severity of the symptoms often correlate with the extent of lesioning. Hemianopsia, or blindness in one-half the visual Weld in each eye is common.

Predictors of longer survival time with PML include lack of clinical progression during the Wrst 2 months of treatment (De Luca et al., 2001) , contrast enhancement and mass eVect (Berger, 2000) in HIV patients, concomitant treatment with HAART and importantly, low JCV virus levels in the CSF (Yiannoutsos et al., 1999) .

There is no established therapy, as yet, for the eVective treatment of PML. Although there have been isolated reports in individual patients, large-scale studies have been diYcult to conduct, due to the limited number of possible test subjects. Attempts to treat the disease have traditionally been aimed at curing the underlying immune deWcit, thereby alleviating symptoms of opportunistic infections. Therapies aimed speciWcally against JCV have also been investigated, but with mixed results. Such antiviral therapies are diYcult due to the fact that the drugs not only interfere with the virus but also with the normal functioning of the host cell.

Cytarabine, or Ara-C, is a nucleoside, well established as a chemotherapeutic agent to treat various malignant disorders, but has also been reported to be beneWcial in the treatment of PML patients. Positive case reports, in addition to preliminary results suggesting that the drug may have some activity against JCV in primary human cells in vitro (Hou and Major, 1998) , prompted the undertaking of ACTG 243, the largest clinical trial, as yet, for any opportunistic infection associated with AIDS. HIV infected, biopsy proven PML patients were administered Ara-C, either intravenously or intrathecally, with or without concomitant antiretroviral therapy. Patients were monitored for clinical signs and viral load during treatment. The results from this trial showed that the administration of Ara-C resulted in no statistical diVerence between the outcome of treated patients to untreated controls (Hall et al., 1998) . However, this and other trials investigating Ara-C resulted in data showing the prognostic value of JC viral load in the CSF. Patients with a reduction in the levels of virus present in the CSF had a signiWcant increase in survival time (De Luca et al., 1999; Yiannoutsos et al., 1999) .

Cidofovir is an antiviral agent that is active against a broad spectrum of human DNA viruses, best documented in the treatment of cytomegalovirus (CMV) retinitis, a signiWcant complication in AIDS patients, or genital herpes. There have been several reports of success in treating AIDS-related PML with the drug, particulary in European countries. Although failures have been reported, the addition of cidofovir to preexisting antiretroviral therapy in AIDS patients seemed to have improved the symptoms of PML, even in cases where the course of the disease worsened despite highly active antiretroviral therapy (Portilla et al., 2000) . SigniWcant radiological improvements, marked by decreases in the extent of lesions, have also been reported in response to cidofovir therapy (Cardenas et al., 2001) . In contrast, the results from the only clinical trial speciWcally using cidofovir in relation to PML, ACTG protocol 363, were far less encouraging. Reported at the 8 th Conference on Retroviruses and Opportunistic Infections, the preliminary statistical analysis revealed no diVerence in prognosis between patients receiving cidofovir and those without (Marra et al., 2002) .

Since the beginning of the AIDS pandemic, the most common underlying immune deWcit resulting in PML has been HIV infection. Combination retroviral therapy also known as highly active anti-retroviral therapy or HAART has been frequently reported to increase the immune status, clinical and radiological symptoms, and survival times in some PML patients (Inui et al., 1999) . The presence of JCV in the CSF or the initiation of a JCV-speciWc humoral intrathecal response have been used as markers for viral replication and immune status, both of which may possess prognostic value for the progression of PML. This is particularly true with the advent of HAART therapy, which in multicenter analyses has been successfully correlated with longer survival.

However, despite prolonged survival, HAART did not always halt the rapid neurological deterioration of PML, suggesting that early intervention with a drug speciWc for JCV will be necessary to stabilize the destruction of the white matter (Gasnault et al., 1999) . Similar case reports have also shown that patients can develop PML while on HAART therapy, and that a decrease in HIV viral load and increase in CD4þ cell counts does not always correlate with resolution of neurological symptoms, again emphasizing the need for a deWnitive antiviral treatment (Tantisiriwat et al., 1999) . It also appears that the initiation of HAART therapy in patients with a high JC viral load at the time of diagnosis does not have a signiWcant eVect on the surival of the patients following treatment, whereas patients with median or low viral loads at diagnosis do have prolonged survival on HAART (TaouWk et al., 2000) .

One recently completed study retrospectively analyzed a series of PML patients being treated with HAART in three northern Italian neurological clinics. The trial revealed that although approximately 50 percent of the patients did show disease stabilization and longer survival in response to HAART, the rapid immune reconstitution could speed the progression of PML as a result of the circulation of lymphocytes that are actively infected by JCV (Cinque et al., 2001) .

PML is the only human demyelinating disease with a known direct viral infection of oligodendrocytes. It remains a challenge to understand how a virus with such a widespread presence in the normal human population can be targeted so speciWcally to oligodendrocytic destruction in the brain of immune compromised individuals. Once considered exceedingly rare, PML has been given much attention recently due to the continual rise in the incidence of AIDS and other immunosuppressive disorders due to chemotherapy in cancer patients and preventative measures against graft rejection in transplant recipients. Since the majority of the population has already been infected with JCV, and a signiWcant percentage of AIDS patients will develop the disease, it is critically important to establish an eVective treatment regimen and develop methods to screen severely immunocompromised patients for the potential risk of developing PML.

Although the plaques of MS on gross brain and spinal cord specimens had been previously described, the clinical complex of multifocal remitting and relapsing disease and pathological correlation with plaques of sclerosis was made by Charcot in 1868. In keeping with his times, he postulated that exposure to cold, physical injury or emotional stress caused the disease. Over the next 15 years, Koch and Pasteur laid the foundations of microbiology and immunology, so it is not surprising that in 1884 Pierre Marie, a student and successor of Charcot as Professor of Neurology in Paris, proposed a microbial cause of MS. Indeed, in the afterglow of Pasteur's discovery of a post-exposure vaccine to protect against rabies, Marie prematurely predicted that a vaccine would soon be available for MS.

Speculation concerning an infectious agent as a cause of MS has recurred over the past century but has gained greater credence over the past 50 years because of three areas of investigation: (1) epidemiologic studies have suggested that MS results, in part, from a childhood environmental exposure followed by a long latency; (2) studies of viral diseases of animals and humans have documented that infections can have long incubation periods, give rise to relapsing and remitting courses, and cause demyelination; (3) studies of patients with MS have consistently shown abnormal immune responses to viral antigens, particularly the intrathecal synthesis of antibodies to viral antigens.

MS is deWned as a demyelinating disease of the CNS with lesions separated in space and time and in which other diagnoses have been ruled out. Before the recovery of Borellia burgdorferi or the human T-cell lymphotropic virus, some cases of Lyme disease and tropical spastic paraparesis fell within the deWnition of MS. We may view these observations from two perspectives: (1) in the past we made erroneous diagnoses now corrected by greater knowledge or (2) what we deWne as MS may have multiple causes and manifestations, and with more speciWc diagnoses the syndrome will become better and more narrowly deWned.

The epidemiology, pathology, and clinical features of MS are comprehensively covered in other chapters. Discussion in this chapter will focus on features suggesting possible infectious causes.

The prevalence of MS is highly variable, dependent on geography and ethnicity. The prevalence of over 200 per 100,000 in the Shetland and Orkney Islands of the North Atlantic contrasts with prevalences approaching 1 per 100,000 in areas of Africa. This variance is not explained by clinical sophistication or quality of health care as once believed. Even within Europe and North America a north/south gradient or zones exist with higher incidence related to higher latitude. This appears to be reXected in the Southern Hemisphere, where the incidence of MS is higher in southern than northern areas of Australia and higher on the south than the north island of New Zealand (Kurtzke, 1993) .

In Northern Europe, Canada, and the Northern United States, prevalence rates are high and range from 30 to 80 cases per 100,000. In Southern Europe and the Southern United States, moderate rates of 6 to 29 are usual. Low prevalence rates are deWned as those below 5 per 100,000 and prevail in Northern South America and all known areas of Africa and Asia. Remarkable exceptions to the general correlation of latitude to prevalence are exempliWed by the absence of MS in Eskimos, and a prevalence in excess of 150 per 100,000 in Sardinia (Montomoli et al., 2002) . The incidence of MS is clearly tied to geography, but whether this reXects immigration routes of Northern Europeans carrying susceptibility genes, or whether it reXects regional exposure still provokes controversy.

MS is more common in women than men in all regions, which supports the postulated immune-mediated pathogenesis. Distribution among racial groups is also unequal; it is more common in whites than Asians, and more common in Asians than African Americans. This supports genetic factors in causation, but it is diYcult to accredit this solely to genetic factors since the prevalence in non-whites in the United States increases with increasing latitude, implicating the importance of environmental agents (Lowis, 1988) . MS prevalence also correlates to a lesser extent with higher socioeconomic class and urbanization.

Little data are available to determine whether the prevalence of MS has increased over time. The increasing identiWcation of occasional cases in those ethnic group previously thought to be spared from the disease (native-born Andeans residents, black South Africans, Eastern European gypsies, etc.) may represent better medical care and availability of imaging or may represent a genuine spread of MS to previously unaVected populations. In Rochester, Minnesota, a stable rate was noted for many years and a more recent survey showed a striking rise (Wynn et al., 1990) . Prevalence data are hard to compare, since the earlier diagnosis and longer survival increase prevalence rates and incidence rates are less accessible

The risk of MS is signiWcantly increased in the siblings and progeny of MS patients. This is striking in twins where the Canadian study has shown monozygotic twins had a concordance rate of 30.8% and dizygotic sex-alike twins had a concordance rate of 4.7% (Sadovnick et al., 1993) . This strengthens the long recognized genetic component of causation; however, 70% of the monozygotic twins were discordant suggesting important nongenetic factors. The Canadian study subsequently evaluated adopted, nonbiological relatives and could Wnd little eVect of shared environment (Ebers et al., 1995) .

Studies of populations migrating from high-risk regions to low-risk regions and studies of patterns of disease on North Atlantic islands have provided the strongest support for the role of a childhood exposure followed by a long incubation period. These investigations began after World War II when Dean (1970) observed that the majority of patients with MS in South Africa were immigrants from the United Kingdom or Northern Europe, even though they made up less that 10% of the population. He determined a prevalence of 50 per 100,000 in this population, compared with 11 per 100,000 in native born English-speaking South Africans, 3 per 100,000 in white Africaans speaking natives, and absence of MS in black, native-born South Africans. Further analysis showed that migration prior to age 15 years led to a risk similar to that of native born English South Africans; and migration as an adult resulted in a risk similar to that of the country of origin (Dean and Kurtzke, 1971) . Similar risk of early life exposure for migrants have been reported from Israel, Australia, Hawaii, and the Antilles. Recent studies of migrants from the United Kingdom and Ireland to varied latitudes in Australia showed prevalence in migrants was considerably less than their country of origin, but did not show a shift at age 15, suggesting that environmental factors may operate over a period of many years and not only in childhood (Hammond et al., 2000) . Studies of migrants from low risk regions to high risk regions suggest a similar phenomenon but are less complete.

Similar evidence of early life exposure is provided by studies of World War II veterans. In the United States, residence at birth and military induction showed a sharp north to south diVerential in risk for MS. Residence after induction and at the onset of disease showed no geographic correlation indicating that risk was acquired prior to conscription (Beebe et al., 1967) .

Continental incidence rates appear rather stable, but studies of island populations of Norse ancestry in the North Atlantic have shown Xuctuations suggesting epidemics. Prevalence rates on the Shetland and Orkney Islands repeatedly showed the highest rates worldwide, but the breakdown of incidences of new cases per year show an abrupt upsurge in the late 1930s, and an equally sudden decline in new cases in 1971, suggesting an epidemic during the intervening 3 decades (Kurtzke, 2000) The data from the Faeroe Islands are even more dramatic. No cases of MS were documented prior to 1943; then 16 patients had onsets between 1943 and 1949 with three subsequent waves of cases. The onset of the initial outbreak coincided with the British occupation of the islands from 1940 to 1945, and detailed analysis showed a spatial relationship between villages where MS patients lived and where British troops had been quartered. The studies in the Faeroes have concluded that MS is not only an acquired disease but that it is a transmissible disease (Kurtzke, 2000) .

MS has long been recognized in Iceland, but a reexamination of their rates show a rise in incidence in 1922, which plateaued until 1945 when a rise in incidence occurred over the subsequent decade. Again this followed the occupation by American, Canadian, and British military forces.

Although late childhood or adolescent infection with a virus, followed by a long incubation has been suggested by epidemiological investigations, very little data implicate a speciWc agent. A number of reports conWrm that measles and other common childhood infections occur at a more advanced age in MS patients than in controls (Bachmann and Kesselring, 1998) . A history of infectious mononucleosis is more frequent in MS patients, indicating later infection, since infections with the ubiquitous EB virus are generally asymptomatic in children and manifest with mononucleosis only when infections is delayed until adolescence and young adult life. These Wndings favoring late acquisition of common infections simply may reXect that persons who develop MS may have had more sheltered childhoods.

An unexplained north to south gradient of varicella-zoster virus infection occurs with chickenpox being an almost universal disease of elementary school children in temperate zones and an infrequent disease of children in the tropics. In the tropics more adult cases, and even adult epidemics, occur (Ross, 1998 ). An excess of spring births of persons who develop MS has been cited to implicate an infectious etiology, but this correlation would implicate maternal or neonatal infection, which is not consistent with the migration studies.

Animal exposures have been investigated extensively. Initially, the Faeroe Island outbreak was postulated to be related to canine distemper virus, a viral infection thought to have been imported by the British oYcers' dogs. Subsequently a cluster of MS cases in Sitka, Alaska, was noted to have followed a canine distemper outbreak 4 to 5 years previously (Cook and Dowling, 1982) . Studies of MS patients have not conWrmed antibody responses to canine distemper speciWc polypeptides.

Patients often relate exacerbations of MS to psychological stress, physical trauma or physical fatigue, but prospective studies quite consistently show a relationship only with symptoms of respiratory infections (Casetta and Granieri, 2000; Marrie et al., 2000) . A recent study extended the Wndings to show that exacerbations in the contest of a systemic infections lead to more sustained damage (Buljevac et al., 2002) .

A number of studies have also examined activation of human herpesviruses with exacerbations, particularly EB virus and human herpesvirus 6 (HHV6), but also active replication of herpes simplex type 1 has been associated with exacerbations (Ferrante et al., 2000) . The obvious dilemma in these studies is the precise timing of the onset of the exacerbation and the activation of the latent virus-that is, determining which came Wrst.

Electron microscopic studies in 1964 identiWed papovavirus particles in inclusion bodies of PML and in 1965 identiWed structures resembling morbillivirus nucleocapsids in the inclusions in subacute sclerosing panencephalitis. Amid the exuberance over Wnding viruses by electron microscopy of poorly Wxed autopsy and biopsy tissues, a number of studies reported ''viruslike'' particles in MS brains. The ovoid membrane bodies of 30 to 200 nm in diameter are now thought to represent myelin breakdown products, the dense intracytoplasmic granules of 60 to 80 nm diameter probably represent nonspeciWc changes in reactive astrocytes, and the intranuclear structures in inXammatory cells originally identiWed as myxovirus nucleocapsids are now believed to be nonspeciWc alterations in nuclear chromatin. None of these or other structures have been deWnitively identiWed as viral in nature .

Although the neuropathology of MS in covered in Chapter 31, one perspective of the pathology that may be relevant to causation is the heterogeneity of lesions in MS. Lucchinetti, et al. (2000) analyzed acute demyelinating lesions in 51 biopsies and 32 autopsies from MS patients. All cases contained at least one active lesion with inXammation, macrophages with myelin debris, and demyelination. CD3 T cells, macrophages, and occasional plasma cells characterized all patterns, but in some cases the demyelination was perivenular and in others not. Some had plaques with sharp margins, others were ill-deWned. In some, oligodendrocytes persisted in demyelinated foci and remyelination was evident, in others apoptosis of oligodendrocytes was associated with wider loss of myelin associated glycoprotein. Despite this heterogeneity there was homogeneity among active lesions in the same patient. They divided the cases into four patterns, but the parallels of some to ADEM and others to PML are very suggestive of diVerent modes of pathogenesis.

In viral diseases, consistency of a clinical-pathological syndrome does not imply a single causative agent. When lymphocytic choriomeningitis virus was recovered from spinal Xuid it was regarded as the cause of benign aseptic meningitis, yet subsequent studies have implicated more than 100 diVerent viruses in that syndrome. Conversely a single virus can evoke varied clinical-pathological responses such a varicella-zoster virus which can cause ADEM, Reye's disease, acute myelitis, vasculitis, and postherpetic neuralgia.

Among clinical laboratory tests, the intrathecal synthesis of IgG and the presence of spinal Xuid oligoclonal bands are hallmarks of MS. Other diseases that consistently show these abnormalities are infectious processes-neurosyphilis, neuroborreliosis, subacute sclerosing panencephalitis, HTLV-1 associated myelitis, and other chronic infections. In these diseases, intrathecal antibodies can be shown to react with viral antigens; the antigen(s) in MS are unknown but the analysis of IgG heavy chain sequences in MS brains suggest an antigen driven response rather than a nonspeciWc B-cell activation (Smith-Jensen et al., 2000) .

Studies of patients with MS have implicated poxviruses, herpesviruses, rhabdoviruses, orthomyxoviruses, paramyxoviruses, coronaviruses, Xaviviruses, picornaviruses, retroviruses, and a variety of unclassiWed or mythical agents. Several parasites and bacteria have also been implicated. Assays of antibodies in serum and in spinal Xuid have consistently shown higher titers of various antibodies in MS patients than in controls, inoculations of patient Xuids or tissues into cell cultures or laboratory animals have shown changes interpreted as evidence of virus replication, or Wnally the change in quantity or topography of an agent known to persist in humans has been interpreted as suggesting a causal relationship to MS.

In 1962, the Wrst report appeared that titers of antibodies to measles virus were higher in the serum of MS patients than controls. The same antibodies were detectable in the spinal Xuids of 75% of MS patients and not in spinal Xuids of controls (Adams and Imagawa, 1962) . Initially, these Wndings were regarded with skepticism, but study after study conWrmed these odd Wndings; more than 30 conWrmations have been published. Subsequently other studies showed higher titers and intrathecal synthesis of antibodies to a variety of other viruses, but never with the magnitude or consistency of measles antibodies (Tab. 40.4) . In one study, 23% of patients with MS had disproportionately high antibodies to 2 or more viruses in the spinal Xuid (Norrby et al., 1974) ; in another study one patient was reported who had evidence of intrathecal synthesis of antibody to 11 diVerent viruses (Salmi et al., 1983) . In general, twin studies have shown higher levels in antibody in the serum or spinal Xuid of the aVected twin than of the healthy twin (Kinnunen et al., 1990) .

The range of responses has suggested a nonspeciWc activation of B cells, but responses against one protein of a virus and not another (Nath and Wolinsky, 1990) , and studies of the antibody variable regions suggest a more speciWc response. The Wnding of higher serum antibody titers to measles is not speciWc to MS. Similar higher titers have been reported in systemic lupus erythematosus, chronic hepatitis, and Reiter syndrome. In MS, as in these other diseases, individual levels of antimeasles antibody are not remarkable, as they are in subacute sclerosing panencephalitis, but the mean titer of large group of patients is consistently higher than the mean of a group of matched controls. Furthermore, measles infection is not a prerequisite to MS, since cases of MS have been observed, presenting prior to the acquisition of measles. 

Recovery of agents from MS has a colorful history. During the Wrst half of the 20th century extensive interest was given a putative spirochete. In 1917, the agent was claimed to have been recovered from the spinal Xuid of patients with MS inoculated into guinea pigs and rabbits. In 1952, direct staining of the agent in brain and spinal cord led to its naming as Spirochaeta myelophthora (Steiner, 1952) . Interest was rekindled in 1957 with further claims of cultivation of spirochetes from spinal Xuids (Ichelson, 1957) , claims that later reports failed to conWrm. This controversy was Wnally settled by extensive negative results using the precise methods recommended for cultivation but substituting autoclaved water (Kurtzke et al., 1962) .

In the 1930s in England, an organism tentatively named Spherula insularis, possibly a Mycoplasma, was reported to have been isolated from spinal Xuid of 176 of 189 patients with MS (Chevassut, 1930) . A vaccine was made, and more than 100 patients were given the vaccine prior to an abrupt retraction (Purves-Stewart, 1931) . In 1956, Toxoplasma gondii was alleged to have been isolated from spinal Xuid and blood of MS patients, but that too went unconWrmed. A number of claims of transmission to primates and other animals were made, but agents were not characterized and results remained unconWrmed (Johnson, 1985) .

The Wrst recovery of a virus that evoked serious consideration was the 1946 Soviet claim of recovery of a virus in mice inoculated with spinal Xuid and brain tissue of two patients with MS (Margulis et al., 1946) . The virus was shown independently to be rabies virus; whether the patient diagnosis was wrong or the agents were laboratory contaminants was unknown. No laboratories conWrmed the isolations, although the original laboratory reported subsequent similar isolations.

In 1964, herpes simplex virus was recovered from the spinal Xuid of a patient with MS (Gudnadottir et al., 1964) . This virus subsequently was shown to be a type 2 herpes simplex strain; the type that has subsequently be isolated frequently from spinal Xuid in recurrent meningitis. This may also represent the Wrst isolation of ''normal Xora'' from MS specimens and the beginning of the persistent question of cause or eVect.

Some of the viruses on Table 40 .5 have subsequently been retracted as laboratory contaminants (scrapie and measles), some are thought to represent animal viruses recovered from inoculated laboratory animals (chimpanzee cytomegalovirus and corona- virus), and some probably do not represent viruses but only laboratory observations interpreted as representing viral activity not veriWed in independent laboratories (MSassociated agent and SMON virus). A critique of these reported isolations previously has been published (Johnson, 1998) . During the National Institutes of Health studies of slow infections, tissues from MS patients were inoculated into chimpanzees. No evidence of transmission has been observed over the subsequent 30 years. This is not deWnitive evidence against a viral cause, however. During those studies tissue from PML and subacute sclerosing panencephalitis, diseases now known to be caused by viruses, were similarly inoculated into chimpanzees with negative long-term observations.

Over the past 5 years the literature on infectious agents and MS has been dominated by studies of the herpesviruses, EB and human herpesvirus 6 (HHV6), endogenous retroviruses, and a bacterium, Chlamydia pneumoniae. In contrast to prior attempts to recover a unique MS virus, these all represent ubiquitous agents that persist in humans, and studies have focused on quantitation and cellular sites of infection. In each case the diYcult question is whether changes are related to causation or whether replication and host cells changes are secondary to the immunological changes in MS.

Interest continues in the long postulated role of EB virus in MS. As mentioned earlier, the age of acquisition determines disease in this infection. Early life infections, as occur in tropical climes and impoverished communities, lead to immunity but no clinical illness; delayed infections in adolescence and young adult life often lead to the syndrome of infectious mononucleosis. Furthermore, even in case-controlled studies MS patients report a greater frequency of preceding infectious mononucleosis. Prevalence of antibodies to EB virus in MS patients is greater than in controls, and in most studies 100% have antibodies against EB, an extent of seropositivity unique to EB virus. A number of authors have suggested that EB infection is a prerequisite to development of MS (Ascherio and Munch, 2000; Munch et al., 1998; Myhr et al., 1998) Longitudinal studies have also found an association between EB virus activation and disease activity in MS patients (Wandinger et al., 2000) ).

There have been several reports of patients with neurological complications of primary EB virus infections who went on to develop progressive or relapsing disease subsequently diagnosed as MS (Bray et al., 1992; Shaw and Alvord, 1987) . One 6-year-old had 11 episodes of relapsing disease with high titers of EB antibodies. At death, the neuropathological diagnosis was typical MS, and PCR of the brain showed EB virus sequences (Pedneault et al., 1992) .

EB virus maintains latency in B cells, which are not present, or at least very rare, in normal nervous tissue. B cells are a feature of the inXammatory response in MS and other inXammatory and infectious diseases. Therefore, the presence of EB DNA determined by PCR may only reXect the presence of B cells; detection of viral proteins in cells or infectious virus in brain or spinal Xuid are evidence of active infection, but again this could represent nonspeciWc activation during the attack of MS.

Human herpesvirus 6 HHV6 is a recently recovered human herpesvirus. The virus is ubiquitous with a 70 to 100% seroprevalence in adult populations worldwide. Two variants have been distinguished, and the B variant is the predominant cause of exanthem subitum in childhood. Encephalitis has long been a recognized complication of exanthem subitum. After primary infection, HHV6 remains latent primarily in T cells, but the virus is pleiotropic, with latency in B cells and CNS glial cells having been reported (Soldan et al., 2001) .

Similar with many other viruses, higher levels of serum antibodies and presence of spinal Xuid antibodies to HHV6 were reported in many MS patients. In addition, HHV6 DNA was detected in spinal Xuid by PCR (Wilborn et al., 1994) . The report by Challoner and colleagues in 1995 made HHV6 a serious candidate as the cause of MS. They found HHV6 DNA in the majority of MS and control brains, but protein expression was primarily in MS brains. Furthermore, immunocytochemical staining showed positive meningeal cells in both groups, but in MS lesions there was staining of cells adjacent to the plaques thought to be neurons and oligodendrocytes. Many conXicting publications have followed. HHV6 IgM in serum and spinal Xuid, higher titers of antibodies in serum, and higher frequency of antibody in spinal Xuid have all been reported in MS patients compared to controls; and all of these Wndings have been refuted in other studies. More frequent detection of HHV6 DNA in peripheral blood mononuclear cells, serum, spinal Xuid, and brain of MS patients have been reported; and again others have failed to conWrm the claims. In one study of lymphoproliferative responses to HHV6 antigens by MS patients, more frequent responses of patients was found to the A variant, although most data has implicated the B variant (Soldan et al., 2000) .

Several reported results raise a need for conWrmation or extension. One group reported immunocytochemical staining in 90% of sections showing active demyelinating lesions and only 13% in tissue sections free of active disease (Knox et al., 2000) ; this level of sensitivity and speciWcity is unique among reports. Recently elevated serum and spinal Xuid levels of membrane cofactor protein CD46 were reported in MS patients; this is important because CD46 is a receptor for HHV6 (as well as measles, the traditionally most implicated virus) and is a regulator of the complement cascade involved in antibody mediated immunopathology (Soldan et al., 2001) . This provocative Wnding may lead to new mechanisms by which viruses might evoke in immune-mediated diseases.

Endogenous retroviruses Human endogenous retroviruses (HERVs) are DNA sequences present within human chromosomes and make up about 2% of the human genome. The characteristic presence of long terminal repeats followed by gag, pol, and env genes identify their retroviral origins; they are thought to represent ancestral infections in which integrated DNA is now passed on in Mendelian fashion. Comparisons to ERVs of apes and old world monkeys suggest that some entered our genome 25 million years ago (Voisset et al., 1999) . HERVs are defective in that they do not code infectious particles or transmit horizontally. Some do encode functional proteins, and complementation may result in virion formation.

No endogenous retroviruses have been convincingly associated with human disease. The potential to enhance downstream cellular genes has led to speculation that they might be involved in autoimmune disease. They have been proposed as factors in the pathogenesis of MS, systemic lupus erythematosus, Sjogren's disease, and type 1 diabetes (Perron and Seigneurin, 1999) .

In 1991 a retrovirus was reported budding from a cell line of meningeal cells established from the spinal Xuid of a patient with MS (Perron et al., 1991) . Subsequently, C-type retrovirus particles were found in peripheral blood mononuclear cells cultured from several patients with MS, but this proved to be a diVerent HERV (Christensen et al., 1998) .

Several recent studies suggest that increased expression of these viruses is a consequence of immune activity rather than the cause. Johnston et al. (2001) showed that levels of HERV RNA increased in cultured macrophages nonspeciWcally stimulated in vitro; several HERVs were also expressed in brain tissue of patients with human immunodeWciency virus infections and with MS, correlating with tumor necrosis factor expression and macrophage activation. In another study (Dolei et al., 2002) , analysis of blood for HERV reported detection in all MS patients, most patients with other inXammatory neurological disease and rarely in healthy donors. The role of these viruses as cofactors rather than simply secondary responders remains unclear.

Chlamydia pneumoniae C. pneumoniae is an obligate intracellular Gram-negative bacterium. It is a common respiratory pathogen causing pharyngitis, bronchitis and atypical pneumonia. Seroprevalence is 40 to 70% in adults, with most seroconversions occurring during adolescence. Numerous attempts to relate C. pneumoniae to chronic disease have been made, most notably coronary artery disease and atherosclerosis. Because the bacteria persist in human macrophages, PCR studies of tissues with macrophage inWltrates often are positive.

After observing a single patient with apparent acute MS from whom C. pneumonia was recovered from spinal Xuid and who improved with antibiotic therapy, the Vanderbilt group undertook an extensive study. From spinal Xuid of MS patients, they cultured C. pneumoniae from 64% but recovered bacteria from only 11% of spinal Xuids from patients with other diseases. PCR was positive in 97% compared to 18% in control patients. Spinal Xuid IgG directed against the bacterium was found in 97%, compared to 18% with other neurological diseases (Sriram et al., 1999) . Subsequently they reported that oligoclonal bands in spinal Xuids of patients with MS not only reacted with C. pneumoniae antigens (116 of 17 patients) but could be partially or completely adsorbed by antigens (Yao et al., 2001) . A large number of contradictory reports have followed. Some have been conWrmatory to some facets, but none with the high percentages of the initial report; the majority have been negative A recent report, for example, using PCR detected C. pneumoniae in spinal Xuid of 21% of MS patients, in 43% of patients with other neurological diseases, and in no healthy controls (GieVers et al., 2001) . This would suggest that inXammatory responses that recruit macrophages into the spinal Xuid, where under normal circumstances they are not found, can carry in C. pneumonia. Better standardization of both cultivation and PCR methods are needed before fair comparisons of studies can be made.

It is clear that a diverse array of viruses can infect the human central nervous system. The resulting viral infections can result in a wide variety of clinical and pathological symptoms. While some viruses may cause widespread inXammation and neurodegeneration, other viruses may remain latent in the CNS and only produce pathological changes during reactivation. Viral induced demyelination can occur both from direct infection of the myelin-producing oligodendrocytes, as in PML, or by indirect mechanisms that have yet to be determined. The Wnal outcome of a viral CNS infection will depend not only on viral characteristics, but also the interaction between virus and host cell. Understanding factors such as immune modulation and host cell regulation of viral gene expression could improve current methods of diagnosis or even lead to innovative methods for therapeutic intervention.

Autoantibodies in childhood post-varicella acute cerebellar ataxia

Measles antibodies in multiple sclerosis

Genotype proWle of human polyomavirus JC excreted in urine of immunocompetent individuals

Progressive multifocal leukoencephalopathy: A review of the pathology and pathogenesis

Epstein-Barr virus and multiple sclerosis

Activity of JC virus archetype and PML-type regulatory regions in glial cells

Multiple sclerosis and infectious childhood diseases

Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II

Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis

Progressive Multifocal Leukoencephalopathy

Progressive Multifocal Leukoencephalopathy. In ''Textbook of AIDS Medicine

Corticosteroid treatment of acute meningoencephalitis: A retrospective study of 346 cases

Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection

Virus-associated neurological syndromes

Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world

Prospective study on the relationship between infections and multiple sclerosis exacerbations

The eVects of cidofovir on progressive multifocal leukoencephalopathy: An MRI case study

Simian virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein

Clinical infections and multiple sclerosis: Contribution from analytical epidemiology

The etiology of disseminated sclerosis

Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy

Polyomavirinae: The viruses and their replication

Distemper and multiple sclerosis in

Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy

Potent anti-retroviral therapy with or without cidofovir for AIDSassociated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study

The multiple sclerosis problem

On the risk of multiple sclerosis according to age at immigration to South Africa

Postvaccinal Perivenous Encephalitis

Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

Brain endothelial cell infection in children with acute fatal measles

Simian virus 40 large T antigen: The puzzle, the pieces, and the emerging picture

JC virus and simian virus 40 enhancers and transforming proteins: Role in determining tissue speciWcity and pathogenicity in transgenic mice

Regulation of the host range of human papovavirus JCV

Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack

Human polyomavirus JC virus genome

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity

Prolonged survival without neurological improvement in patients with AIDSrelated progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy

Neurological complications of glandular fever (infectious mononucleosis)

A quantitation of myelin-associated glycoprotein and myelin basic protein loss in diVerent demyelinating diseases

Measles encephalomyelitis: Lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination

Electroencephalographic abnormality i ''uncomplicated'' childhood diseases

Presence of Chlamydia pneumoniae DNA in the cerebral spinal Xuid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis

Transient dystonia as a complication of varicella

Virus isolated from the brain of a patient with multiple sclerosis

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeWciency virus infection. AIDS Clinical Trials Group 243 Team

Eigennartige und nicht rubriziebare Prozesse

The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia

Haemorrhagic and perivenous encephalitis: A clinical-pathological review of 38 cases

ADEM: Distinct disease or part of the MS spectrum

Immunologic studies of patients with chronic encephalitis induced by post-exposure Semple rabies vaccine

Ependymitis in mumps virus meningitis. Electron microscopical studies of cerebrospinal Xuid

Cellular immune responses during complicated and uncomplicated measles virus infections of man

Epidemiology of progressive multifocal leukoencephalopathy in the United States: Analysis of national mortality and AIDS surveillance data

The eYcacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line

InXuenza encephalopathy and post-inXuenzal encephalitis: Histological and other observations

Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children

Cultivation of spirochaetes from spinal Xuids of multiple sclerosis cases and engative controls

Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection

Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection

Acute disseminated encephalomyelitis developed after acute herpetic gingivostomatitis

Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS

Mumps virus encephalitis in the hamster. Studies of the inXammatory response and noncytopathic infection of neurons

Viral aspects of multiple sclerosis

Viral Infections of the Nervous System

Measles encephalomyelitis-clinical and immunologic studies

Postinfectious encephalomyelitis

Virologic studies of multiple sclerosis and other chronic and relapsing neurological diseases

Monocyte activation and diVerentiation augment human endogenous retrovirus expression: Implications for inXammatory brain diseases

The rapid production of acute disseminated encephalomyelitis in rhesus monkey by injection of heterologous and homologous brain tissue with adjuvants

Mechanism of suppression of cell-mediated immunity by measles virus

Persistent expression of Ia antigen and viral genome in visna-maedi virusinduced inXammatory cells. Possible role of lentivirus-induced interferon

Viral antibodies in multiple sclerosis. A nationwide co-twin study

Human herpesvirus 6 and multiple sclerosis: Systemic active infections in patients with early disease

Epidemiologic evidence for multiple sclerosis as an infection

Multiple sclerosis in time and space-geographic clues to cause

Microbiology in multiple sclerosis-evaluation of Ichelson's organism

JC virus DNA is present in the mucosa of the human colon and in colorectal cancers

Neurologic disorders following live measles-virus vaccination

Autoimmunity due to molecular mimicry as a cause of neurological disease

A hyperacute form of allergic encephalomyelitis

Guillain-Barre syndrome and Hodgkin's disease: Three cases with immunological studies

Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids

Ethnic factors in multiple sclerosis: A review and critique of the epidemiological literature

Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

Aetiology and pathogenesis of acute sporadic disseminated encephalomyelitis and multiple sclerosis

A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS

Multiple sclerosis and antecedent infections: A case-control study

Acute perivascular myelinoclasis (''acute disssemination encephalopmyelitis'') in smallpox

Prognosis of neurologic illness following vaccination against smallpox

Neurological sequelae of prophylactic inoculation

Acute measles in patients with and without neurological involvement: Distribution of measles virus antigen and RNA

Detection of JC virus DNA in human tonsil tissue: Evidence for site of initial viral infection

JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor

An ecologic study of geographical variation in multiple sclerosis risk in central Sardinia

Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: Contribution of gastrointestinal infections to autoimmunity

Characterization of a nuclear localization sequence in the polyomavirus capsid protein VP1

The signiWcance of Epstein-Barr virus seropositivity in multiple sclerosis patients?

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: A population based case-control study from western Norway

Acute disseminated encephalomyelitis as manifestation of primary HIV infection

Antibody response to rubella virus structural proteins in multiple sclerosis

Comparison of antibodies against diVerent viruses in cerebrospinal Xuid and serum samples from patients with multiple sclerosis

On changes in the cerebrospinal Xuid during measles

Distribution and function of JCV agnoprotein

Acute disseminated encephalomyelitis associated with poliomyelitis vaccine

Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

Acute arcuate Wber demyelinating encephalopathy following Epstein-Barr virus infection

Transfer of allergic encephalomyelitis in rats by means of lymph node cells

Detection of Epstein-Barr virus in the brain by the polymerase chain reaction

Isolation of retrovirus from patients with multiple sclerosis

Human retroviral sequences associated with extracellular particles in autoimmune diseases: Epiphenomenon or possible role in aetiopathogenesis?

Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature

Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis

Progressive multifocal leukoencephalopathy treated with cidofovir in HIVinfected patients receiving highly active anti-retroviral therapy

Neuroimmune and neurovirological aspects of human immunodeWciency virus infection

Cerebral white matter changes in acquired immunodeWciency syndrome dementia: Alterations of the blood-brain barrier

Disseminated sclerosis-experimental vaccine treatment

Our evolving understanding of progressive multifocal leukoencephalopathy

Acute disseminated encephalomyelitis (ADEM) due to Mycoplasma pneumoniae infection in an adolescent

Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys

The varicella-zoster virus and multiple sclerosis

Acute disseminated encephalomyelitis associated with hepatitis C virus infection

A population-based study of multiple sclerosis in twins: Update

Intrathecal antibody synthesis to virus antigens in multiple sclerosis

Meningoencephalomyelitis with epidemic parotitis

Common structural antigen of papovaviruses of the simian virus 40-polyoma subgroup

Multiple sclerosis beginning in infancy

Fulminating encephalopathy with perivenular demyelination and vacuolar myelopathy as the initial presentation of human immunodeWciency virus infection

Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response

Elevated serum and cerebrospinal Xuid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis

Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients

The neurology of Jennerian vaccination: A clinical account of the neurological complications which occurred during the smallpox epidemic in South Wales in 1962

Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis

Acute plaques in multiple sclerosis, their pathogenetic signiWcance and role of spirochaetes as etiological factor

Expression of multiple classes of the nuclear factor-1 family in the developing human brain: DiVerential expression of two classes of NF-1 genes

Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy

Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal Xuid at progressive multifocal leukoencephalopathy diagnosis

Progressive multifocal leukoencephalopathy in AIDS: Initial and follow-up CT and MRI

Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy

Nuerological complications of rubeola (measles)

Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and other primates

Das Verhalten der kutanen Tuberkulin-reaktion wahrend der Masern

Brain MRI Wndings in inXuenza A-associated acute necrotizing encephalopathy of childhood

The epidemiology of human polyomaviruses

Association between clinical disease activity and Epstein-Barr virus reactivation in MS

Human anti-JC virus serum reacts with native but not denatured JC virus major capsid protein VP1

A potential role for human herpesvirus type 6 in nervous system disease

Growth of JC virus in adult human brain cell cultures

A reappraisal of the epidemiology of multiple sclerosis in Olmsted County

CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens

Relation of JC virus DNA in the cerebrospinal Xuid to survival in acquired immunodeWciency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy

Corticosteroid treatment for measles encephalitis